BioVaxys LLC (www.biovaxys.com), a clinical-stage immune-oncology company developing a universal vaccine platform for individualized cancer
Source Read More
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2020) - BioVaxys Technology Corp. (CSE: BIOV) (formerly Lions Bay Mining Corp.) ("BioVaxys" or the "Company") is pleased to announc… Read More
BioVaxys Technology Corp., the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into a major bioproduction agreement wit… Read More
Vancouver, British Columbia (ots/PRNewswire) – Gewerbliche Markenanmeldung für den CoviDTH®-Test eingereicht, Patentabdeckung für die Krebsimpfstoff… Read More
Vancouver, British Columbia (ots/PRNewswire) – BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTCQB:BVAXF) (“BioVaxys” oder das “Unternehmen”) freut sich, ei… Read More
Covid-19 Hot Stock erzielt Durchbruch bei Krebsimpfstoff – Kaufsignal. Neuer 567% Covid-19 und Biotech Aktientip nach 1.509% mit Inovio Pharmaceuticals Inc. (NASDAQ:INO) , 3.204% mit… Read More
Vancouver (British Columbia), 17. September 2021. BioVaxys Technology Corp. (CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) (BioVaxys) meldete heute, dass sein Krebsimpfstoff-Herstellungspartner Bio El… Read More
[ad_1]
Vancouver, British Columbia (ots/PRNewswire) – BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) («BioVaxys») gab heute bekannt, dass der Partner f&u… Read More